SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Michaela E. Johnson, Larisa Bobrovskaya, An update on the rotenone models of Parkinson's disease: Their ability to reproduce the features of clinical disease and model gene–environment interactions, NeuroToxicology, 2015, 46, 101

    CrossRef

  2. 2
    Yin Xia Chao, Ebonne Yulin Ng, Louis Tan, Kumar M. Prakash, Wing-Lok Au, Yi Zhao, Eng-King Tan, Lrrk2 R1628P variant is a risk factor for essential tremor, Scientific Reports, 2015, 5, 9029

    CrossRef

  3. 3
    M. Yue, K.M. Hinkle, P. Davies, E. Trushina, F.C. Fiesel, T.A. Christenson, A.S. Schroeder, L. Zhang, E. Bowles, B. Behrouz, S.J. Lincoln, J.E. Beevers, A.J. Milnerwood, A. Kurti, P.J. McLean, J.D. Fryer, W. Springer, D.W. Dickson, M.J. Farrer, H.L. Melrose, Progressive dopaminergic alterations and mitochondrial abnormalities in LRRK2 G2019S knock-in mice, Neurobiology of Disease, 2015, 78, 172

    CrossRef

  4. You have free access to this content4
    Una-Marie Sheerin, Henry Houlden, Nicholas W. Wood, Advances in the Genetics of Parkinson's Disease: A Guide for the Clinician, Movement Disorders Clinical Practice, 2014, 1, 1
  5. 5
    Teeratorn Pulkes, Chutima Papsing, Ammarin Thakkinstian, Sunsanee Pongpakdee, Kongkiat Kulkantrakorn, Suchat Hanchaiphiboolkul, Somsak Tiamkao, Pairoj Boonkongchuen, Confirmation of the association between LRRK2 R1628P variant and susceptibility to Parkinson's disease in the Thai population, Parkinsonism & Related Disorders, 2014, 20, 9, 1018

    CrossRef

  6. 6
    Donna Mae Lyn Buhat, Eng-King Tan, Genetic testing of LRRK2 in Parkinson's disease: is there a clinical role?, Parkinsonism & Related Disorders, 2014, 20, S54

    CrossRef

  7. 7
    Iakov N. Rudenko, Mark R. Cookson, Heterogeneity of Leucine-Rich Repeat Kinase 2 Mutations: Genetics, Mechanisms and Therapeutic Implications, Neurotherapeutics, 2014, 11, 4, 738

    CrossRef

  8. 8
    Aroma Agape Gopalai, Shen-Yang Lim, Jing Yi Chua, Shelisa Tey, Thien Thien Lim, Norlinah Mohamed Ibrahim, Ai Huey Tan, Gaik Bee Eow, Zariah Abdul Aziz, Santhi Datuk Puvanarajah, Shanthi Viswanathan, Irene Looi, Soo Kun Lim, Li Ping Tan, Yip Boon Chong, Chong Tin Tan, Yi Zhao, E. K. Tan, Azlina Ahmad-Annuar, LRRK2 G2385R and R1628P Mutations Are Associated with an Increased Risk of Parkinson’s Disease in the Malaysian Population, BioMed Research International, 2014, 2014, 1

    CrossRef

  9. 9
    April Reynolds, Elizabeth A. Doggett, Steve M. Riddle, Connie S. Lebakken, R. Jeremy Nichols, LRRK2 kinase activity and biology are not uniformly predicted by its autophosphorylation and cellular phosphorylation site status, Frontiers in Molecular Neuroscience, 2014, 7,

    CrossRef

  10. 10
    Da-Wei Li, Zhuqin Gu, Chaodong Wang, Jinghong Ma, Bei-Sha Tang, Sheng-Di Chen, Piu Chan, Non-motor symptoms in Chinese Parkinson’s disease patients with and without LRRK2 G2385R and R1628P variants, Journal of Neural Transmission, 2014,

    CrossRef

  11. 11
    Cheng-long Xie, Jia-Lin Pan, Wen-Wen Wang, Yu Zhang, Su-fang Zhang, Jing Gan, Zhen-Guo Liu, The association between the LRRK2 G2385R variant and the risk of Parkinson’s disease: a meta-analysis based on 23 case–control studies, Neurological Sciences, 2014, 35, 10, 1495

    CrossRef

  12. 12
    Michael G. Heckman, Alexis Elbaz, Alexandra I. Soto-Ortolaza, Daniel J. Serie, Jan O. Aasly, Grazia Annesi, Georg Auburger, Justin A. Bacon, Magdalena Boczarska-Jedynak, Maria Bozi, Laura Brighina, Marie-Christine Chartier-Harlin, Efthimios Dardiotis, Alain Destée, Carlo Ferrarese, Alessandro Ferraris, Brian Fiske, Suzana Gispert, Georgios M. Hadjigeorgiou, Nobutaka Hattori, John P.A. Ioannidis, Barbara Jasinska-Myga, Beom S. Jeon, Yun Joong Kim, Christine Klein, Rejko Kruger, Elli Kyratzi, Chin-Hsien Lin, Katja Lohmann, Marie-Anne Loriot, Timothy Lynch, George D. Mellick, Eugénie Mutez, Grzegorz Opala, Sung Sup Park, Simona Petrucci, Aldo Quattrone, Manu Sharma, Peter A. Silburn, Young Ho Sohn, Leonidas Stefanis, Vera Tadic, Hiroyuki Tomiyama, Ryan J. Uitti, Enza Maria Valente, Demetrios K. Vassilatis, Carles Vilariño-Güell, Linda R. White, Karin Wirdefeldt, Zbigniew K. Wszolek, Ruey-Meei Wu, Georgia Xiromerisiou, Demetrius M. Maraganore, Matthew J. Farrer, Owen A. Ross, The protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variants, Neurobiology of Aging, 2014, 35, 1, 266.e5

    CrossRef

  13. 13
    Huajun Jin, Arthi Kanthasamy, Vellareddy Anantharam, Anumantha G. Kanthasamy, Biomarkers in Toxicology, 2014,

    CrossRef

  14. 14
    Owen A. Ross, A Prognostic View on the Application of Individualized Genomics in Parkinson’s Disease, Current Genetic Medicine Reports, 2013, 1, 1, 52

    CrossRef

  15. 15
    Jiangping Cai, Yi Lin, Wanjin Chen, Qifang Lin, Bin Cai, Ning Wang, Weihong Zheng, Association between G2385R and R1628P polymorphism of LRRK2 gene and sporadic Parkinson’s disease in a Han-Chinese population in south-eastern China, Neurological Sciences, 2013, 34, 11, 2001

    CrossRef

  16. 16
    Yah-Huei Wu-Chou, Ying-Ting Chen, Tu-Hsueh Yeh, Hsiu-Chen Chang, Yi-Hsin Weng, Szu-Chia Lai, Chia-Ling Huang, Rou-Shayn Chen, Ying-Zu Huang, Chiung-Chu Chen, June Hung, Wen-Li Chuang, Wey-Yil Lin, Chien-Hsiun Chen, Chin-Song Lu, Genetic variants of SNCA and LRRK2 genes are associated with sporadic PD susceptibility: A replication study in a Taiwanese cohort, Parkinsonism & Related Disorders, 2013, 19, 2, 251

    CrossRef

  17. 17
    Rachel M. Bailey, Jason P. Covy, Heather L. Melrose, Linda Rousseau, Ruth Watkinson, Joshua Knight, Sarah Miles, Matthew J. Farrer, Dennis W. Dickson, Benoit I. Giasson, Jada Lewis, LRRK2 phosphorylates novel tau epitopes and promotes tauopathy, Acta Neuropathologica, 2013, 126, 6, 809

    CrossRef

  18. 18
    Soraya Bardien, Janine Blanckenberg, Lize Merwe, Matthew J. Farrer, Owen A. Ross, Patient-control association study of the Leucine-Rich repeat kinase 2 (LRRK2) gene in South African Parkinson's disease patients, Movement Disorders, 2013, 28, 14
  19. 19
    Andrew B. Singleton, Matthew J. Farrer, Vincenzo Bonifati, The genetics of Parkinson's disease: Progress and therapeutic implications, Movement Disorders, 2013, 28, 1
  20. 20
    Shinsuke Fujioka, Christina Sundal, Owen A. Ross, Zbigniew K. Wszolek, Handbook of Parkinson’s Disease, 2013,

    CrossRef

  21. 21
    Shinsuke Fujioka, Christina Sundal, Owen Ross, Zbigniew Wszolek, Handbook of Parkinson's Disease, Fifth Edition, 2013,

    CrossRef

  22. 22
    Yishu Zhou, Xiaoguang Luo, Fengrui Li, Xiaofei Tian, Lanhui Zhu, Yichun Yang, Yan Ren, Hao Pang, Association of Parkinson’s disease with six single nucleotide polymorphisms located in four PARK genes in the northern Han Chinese population, Journal of Clinical Neuroscience, 2012, 19, 7, 1011

    CrossRef

  23. 23
    Ignacio F. Mata, Harvey Checkoway, Carolyn M. Hutter, Ali Samii, John W. Roberts, Hojoong M. Kim, Pinky Agarwal, Victoria Alvarez, Renee Ribacoba, Pau Pastor, Oswaldo Lorenzo-Betancor, Jon Infante, María Sierra, Pilar Gómez-Garre, Pablo Mir, Beate Ritz, Shannon L. Rhodes, Amy Colcher, Vivianna Van Deerlin, Kathryn A. Chung, Joseph F. Quinn, Dora Yearout, Erica Martinez, Federico M. Farin, Jia Y. Wan, Karen L. Edwards, Cyrus P. Zabetian, Common variation in the LRRK2 gene is a risk factor for Parkinson's disease, Movement Disorders, 2012, 27, 14
  24. 24
    Justin P. Rubio, Simon Topp, Liling Warren, Pamela L. St. Jean, Daniel Wegmann, Darren Kessner, John Novembre, Judong Shen, Dana Fraser, Jennifer Aponte, Keith Nangle, Lon R. Cardon, Margaret G. Ehm, Stephanie L. Chissoe, John C. Whittaker, Matthew R. Nelson, Vincent E. Mooser, Deep sequencing of the LRRK2 gene in 14,002 individuals reveals evidence of purifying selection and independent origin of the p.Arg1628Pro mutation in Europe, Human Mutation, 2012, 33, 7
  25. 25
    Sang-Myung Cheon, Lilian Chan, Daniel Kam Yin Chan, Jae Woo Kim, Genetics of Parkinson’s Disease - A Clinical Perspective, Journal of Movement Disorders, 2012, 5, 2, 33

    CrossRef

  26. 26
    Kelly M Hinkle, Mei Yue, Bahareh Behrouz, Justus C Dächsel, Sarah J Lincoln, Erin E Bowles, Joel E Beevers, Brittany Dugger, Beate Winner, Iryna Prots, Caroline B Kent, Kenya Nishioka, Wen-Lang Lin, Dennis W Dickson, Christopher J Janus, Matthew J Farrer, Heather L Melrose, LRRK2 knockout mice have an intact dopaminergic system but display alterations in exploratory and motor co-ordination behaviors, Molecular Neurodegeneration, 2012, 7, 1, 25

    CrossRef

  27. 27
    Xi Wu, Ke-Fu Tang, Yang Li, Yu-Yu Xiong, Lu Shen, Zhi-Yun Wei, Ke-Jun Zhou, Jia-Min Niu, Xia Han, Lun Yang, Guo-Yin Feng, Lin He, Sheng-Ying Qin, Quantitative assessment of the effect of LRRK2 exonic variants on the risk of Parkinson’s disease: A meta-analysis, Parkinsonism & Related Disorders, 2012, 18, 6, 722

    CrossRef

  28. 28
    Owen A Ross, Single gene variants in risk and protection: a new view on the genetic etiology of Parkinson’s disease, Neurodegenerative Disease Management, 2012, 2, 3, 235

    CrossRef

  29. 29
    Xue-Li Chang, Xue-Ye Mao, Hui-Hua Li, Jin-Hong Zhang, Nan-Nan Li, Jean-Marc Burgunder, Rong Peng, Eng-King Tan, Association of GWAS loci with PD in China, American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2011, 156, 3
  30. 30
    Owen A Ross, Alexandra I Soto-Ortolaza, Michael G Heckman, Jan O Aasly, Nadine Abahuni, Grazia Annesi, Justin A Bacon, Soraya Bardien, Maria Bozi, Alexis Brice, Laura Brighina, Christine Van Broeckhoven, Jonathan Carr, Marie-Christine Chartier-Harlin, Efthimios Dardiotis, Dennis W Dickson, Nancy N Diehl, Alexis Elbaz, Carlo Ferrarese, Alessandro Ferraris, Brian Fiske, J Mark Gibson, Rachel Gibson, Georgios M Hadjigeorgiou, Nobutaka Hattori, John PA Ioannidis, Barbara Jasinska-Myga, Beom S Jeon, Yun Joong Kim, Christine Klein, Rejko Kruger, Elli Kyratzi, Suzanne Lesage, Chin-Hsien Lin, Timothy Lynch, Demetrius M Maraganore, George D Mellick, Eugénie Mutez, Christer Nilsson, Grzegorz Opala, Sung Sup Park, Andreas Puschmann, Aldo Quattrone, Manu Sharma, Peter A Silburn, Young Ho Sohn, Leonidas Stefanis, Vera Tadic, Jessie Theuns, Hiroyuki Tomiyama, Ryan J Uitti, Enza Maria Valente, Simone van de Loo, Demetrios K Vassilatis, Carles Vilariño-Güell, Linda R White, Karin Wirdefeldt, Zbigniew K Wszolek, Ruey-Meei Wu, Matthew J Farrer, Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case–control study, The Lancet Neurology, 2011, 10, 10, 898

    CrossRef

  31. 31
    Y. Zheng, Y. Liu, Q. Wu, H. Hong, H. Zhou, J. Chen, H. Wang, W. Xian, J. Li, Z. Liu, Z. Pei, L. Chen, Confirmation of LRRK2 S1647T variant as a risk factor for Parkinson’s disease in Southern China, European Journal of Neurology, 2011, 18, 3
  32. 32
    Soraya Bardien, Suzanne Lesage, Alexis Brice, Jonathan Carr, Genetic characteristics of leucine-rich repeat kinase 2 (LRRK2) associated Parkinson’s disease, Parkinsonism & Related Disorders, 2011, 17, 7, 501

    CrossRef

  33. 33
    Ignacio F. Mata, Greggory J. Wilhoite, Dora Yearout, Justin A. Bacon, Mario Cornejo-Olivas, Pilar Mazzetti, Victoria Marca, Olimpio Ortega, Oscar Acosta, Carlos Cosentino, Luis Torres, Angel C. Medina, Carolina Perez-Pastene, Fernando Díaz-Grez, Carles Vilariño-Güell, Pablo Venegas, Marcelo Miranda, Osvaldo Trujillo-Godoy, Luis Layson, Rodrigo Avello, Elena Dieguez, Victor Raggio, Federico Micheli, Claudia Perandones, Victoria Alvarez, Juan Segura-Aguilar, Matthew J. Farrer, Cyrus P. Zabetian, Owen A. Ross, Lrrk2 p.Q1111H substitution and Parkinson’s disease in Latin America, Parkinsonism & Related Disorders, 2011, 17, 8, 629

    CrossRef

  34. 34
    Chin-Hsien Lin, Pei-I Tsai, Ruey-Meei Wu, Cheng-Ting Chien, LRRK2 Parkinson’s disease: from animal models to cellular mechanisms, Reviews in the Neurosciences, 2011, 22, 4

    CrossRef

  35. 35
    Ling-yan Yao, Ji-feng Guo, Lei Wang, Ren-he Yu, Qi-ying Sun, Qian Pan, Kun Xia, Bei-sha Tang, Lu Shen, LRRK2 Pro755Leu variant in ethnic Chinese population with Parkinson's disease, Neuroscience Letters, 2011, 495, 1, 35

    CrossRef

  36. 36
    Chin-Hsien Lin, Ruey-Meei Wu, Chun-Hwei Tai, Meng-Ling Chen, Fu-Chang Hu, Lrrk2 S1647T and BDNF V66M interact with environmental factors to increase risk of Parkinson’s disease, Parkinsonism & Related Disorders, 2011, 17, 2, 84

    CrossRef

  37. 37
    Yi Zhao, P. Ho, Yuen Yih, C. Chen, W.L. Lee, E.K. Tan, LRRK2 variant associated with Alzheimer's disease, Neurobiology of Aging, 2011, 32, 11, 1990

    CrossRef

  38. 38
    Thomas Gasser, John Hardy, Yoshikuni Mizuno, Milestones in PD genetics, Movement Disorders, 2011, 26, 6
  39. 39
    E. K. Tan, A. H. Schapira, New LRRK2 variants identified in Parkinson’s disease, European Journal of Neurology, 2011, 18, 3
  40. 40
    Joshua M. Shulman, Philip L. De Jager, Mel B. Feany, Parkinson's Disease: Genetics and Pathogenesis, Annual Review of Pathology: Mechanisms of Disease, 2011, 6, 1, 193

    CrossRef

  41. 41
    You-yong Tian, Cui-ju Tang, Jie Wu, Jun-shan Zhou, Parkinson’s disease in China, Neurological Sciences, 2011, 32, 1, 23

    CrossRef

  42. 42
    Hiroyuki Tomiyama, Hiroyo Yoshino, Kotaro Ogaki, Lin Li, Chikara Yamashita, Yuanzhe Li, Manabu Funayama, Ryogen Sasaki, Yasumasa Kokubo, Shigeki Kuzuhara, Nobutaka Hattori, PLA2G6 variant in Parkinson's disease, Journal of Human Genetics, 2011, 56, 5, 401

    CrossRef

  43. 43
    Stanley Fahn, Joseph Jankovic, Mark Hallett, Principles and Practice of Movement Disorders, 2011,

    CrossRef

  44. 44
    Kurt A. Jellinger, Youmans Neurological Surgery, 2011,

    CrossRef

  45. 45
    Lei Wang, Ji-feng Guo, Li-luo Nie, Qian Xu, Xing Zuo, Qi-ying Sun, Xin-xiang Yan, Bei-sha Tang, A novel LRRK2 mutation in a mainland Chinese patient with familial Parkinson's disease, Neuroscience Letters, 2010, 468, 3, 198

    CrossRef

  46. 46
    X.-Y. Mao, J.-M. Burgunder, Z.-J. Zhang, X.-K. An, J.-H. Zhang, Y. Yang, T. Li, Y.-C. Wang, X.-L. Chang, R. Peng, Association between GBA L444P mutation and sporadic Parkinson's disease from Mainland China, Neuroscience Letters, 2010, 469, 2, 256

    CrossRef

  47. 47
    S. Lesage, A. Brice, Bases moléculaires de la maladie de Parkinson, EMC - Neurologie, 2010, 7, 1, 1

    CrossRef

  48. 48
    S. Lesage, A. Brice, Basi molecolari del morbo di Parkinson, EMC - Neurologia, 2010, 10, 2, 1

    CrossRef

  49. 49
    Won-Gi Seol, Biochemical and molecular features of LRRK2 and its pathophysiological roles in Parkinson's disease, BMB Reports, 2010, 43, 4, 233

    CrossRef

  50. 50
    A. I. Soto-Ortolaza, B. Behrouz, C. Wider, C. Vilariño-Güell, M. G. Heckman, J. O. Aasly, J. Mark Gibson, T. Lynch, B. Jasinska-Myga, A. Krygowska-Wajs, G. Opala, M. Barcikowska, K. Czyzewski, R. J. Uitti, Z. K. Wszolek, M. J. Farrer, O. A. Ross, Calbindin-1 association and Parkinson’s disease, European Journal of Neurology, 2010, 17, 2
  51. 51
    Christian Wider, Tatiana Foroud, Zbigniew K. Wszolek, Clinical implications of gene discovery in Parkinson's disease and parkinsonism, Movement Disorders, 2010, 25, S1
  52. 52
    Barbara Jasinska-Myga, Jennifer Kachergus, Carles Vilariño-Güell, Christian Wider, Alexandra I. Soto-Ortolaza, Mounir Kefi, Lefkos T. Middleton, Lianna Ishihara-Paul, Rachel A. Gibson, Rim Amouri, Samia Ben Yahmed, Samia Ben Sassi, Mourad Zouari, Ghada El Euch, Owen A. Ross, Faycal Hentati, Matthew J. Farrer, Comprehensive sequencing of the LRRK2 gene in patients with familial Parkinson's disease from North Africa, Movement Disorders, 2010, 25, 13
  53. 53
    Kumar M Prakash, Eng-King Tan, Development of Parkinson’s disease biomarkers, Expert Review of Neurotherapeutics, 2010, 10, 12, 1811

    CrossRef

  54. 54
    John Hardy, Genetic Analysis of Pathways to Parkinson Disease, Neuron, 2010, 68, 2, 201

    CrossRef

  55. 55
    Karen Nuytemans, Jessie Theuns, Marc Cruts, Christine Van Broeckhoven, Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update, Human Mutation, 2010, 31, 7
  56. 56
    Arianna Tucci, Mike A Nalls, Henry Houlden, Tamas Revesz, Andrew B Singleton, Nicholas W Wood, John Hardy, Coro Paisán-Ruiz, Genetic variability at the PARK16 locus, European Journal of Human Genetics, 2010, 18, 12, 1356

    CrossRef

  57. 57
    Carles Vilariño-Güell, Owen A. Ross, Christian Wider, Barbara Jasinska-Myga, Stephanie A. Cobb, Alexandra I. Soto-Ortolaza, Jennifer M. Kachergus, Brett H. Keeling, Justus C. Dachsel, Heather L. Melrose, Bahareh Behrouz, Zbigniew K. Wszolek, Ryan J. Uitti, Jan O. Aasly, Alex Rajput, Matthew J. Farrer, LINGO1 rs9652490 is associated with essential tremor and Parkinson disease, Parkinsonism & Related Disorders, 2010, 16, 2, 109

    CrossRef

  58. 58
    Soraya Bardien, Angelica Marsberg, Rowena Keyser, Debbie Lombard, Suzanne Lesage, Alexis Brice, Jonathan Carr, LRRK2 G2019S mutation: frequency and haplotype data in South African Parkinson’s disease patients, Journal of Neural Transmission, 2010, 117, 7, 847

    CrossRef

  59. 59
    Owen A. Ross, Greggory J. Wilhoite, Justin A. Bacon, Alexandra Soto-Ortolaza, Jennifer Kachergus, Stephanie A. Cobb, Andreas Puschmann, Carles Vilariño-Güell, Matthew J. Farrer, Neill Graff-Radford, James F. Meschia, Zbigniew K. Wszolek, LRRK2 variation and Parkinson's disease in African Americans, Movement Disorders, 2010, 25, 12
  60. 60
    Manabu Funayama, Hiroyuki Tomiyama, Ruey-Meei Wu, Kotaro Ogaki, Hiroyo Yoshino, Yoshikuni Mizuno, Nobutaka Hattori, Rapid screening of ATP13A2 variant with high-resolution melting analysis, Movement Disorders, 2010, 25, 14
  61. 61
    Jong-Min Kim, Jee-Young Lee, Hee Jin Kim, Ji Seon Kim, Eun-Soon Shin, Jin-Hwan Cho, Sung Sup Park, Beom S. Jeon, The LRRK2 G2385R variant is a risk factor for sporadic Parkinson's disease in the Korean population, Parkinsonism & Related Disorders, 2010, 16, 2, 85

    CrossRef

  62. 62
    Thomas Gasser, Recent Advances in Parkinson’s Disease: Basic Research, 2010,

    CrossRef

  63. 63
    Matthew James Farrer, MOVEMENT DISORDERS 4, 2010,

    CrossRef

  64. 64
    Jessica E. Young, Carles Vilariño-Güell, Siong-Chi Lin, Zbigniew K. Wszolek, Matthew J. Farrer, Clinical and Genetic Description of a Family With a High Prevalence of Autosomal Dominant Restless Legs Syndrome, Mayo Clinic Proceedings, 2009, 84, 2, 134

    CrossRef

  65. 65
    Kristoffer Haugarvoll, Zbigniew K. Wszolek, Clinical features of LRRK2 parkinsonism, Parkinsonism & Related Disorders, 2009, 15, S205

    CrossRef

  66. 66
    Christian Wider, Justus C. Dachsel, Alexandra I. Soto, Michael G. Heckman, Nancy N. Diehl, Mei Yue, Sarah Lincoln, Jan O. Aasly, Kristoffer Haugarvoll, John Q. Trojanowski, Spiridon Papapetropoulos, Deborah Mash, Alex Rajput, Ali H. Rajput, J. Mark Gibson, Timothy Lynch, Dennis W. Dickson, Ryan J. Uitti, Zbigniew K. Wszolek, Matthew J. Farrer, Owen A. Ross, FGF20 and Parkinson's disease: No evidence of association or pathogenicity via α-synuclein expression, Movement Disorders, 2009, 24, 3
  67. 67
    Owen A. Ross, James F. Meschia, Genetics of ischemic stroke: Inheritance of a sporadic disorder, Current Neurology and Neuroscience Reports, 2009, 9, 1, 19

    CrossRef

  68. 68
    B. Jasinska-Myga, C. Wider, G. Opala, A. Krygowska-Wajs, M. Barcikowska, K. Czyzewski, M. Baker, R. Rademakers, R. J. Uitti, M. J. Farrer, O. A. Ross, Z. K. Wszolek, GRN 3′UTR+78 C>T is not associated with risk for Parkinson’s disease, European Journal of Neurology, 2009, 16, 8
  69. 69
    Owen A. Ross, Cleanthe Spanaki, Alida Griffith, Chin-Hsien Lin, Jennifer Kachergus, Kristoffer Haugarvoll, Helen Latsoudis, Andreas Plaitakis, Joaquim J. Ferreira, Cristina Sampaio, Vincenzo Bonifati, Ruey-Meei Wu, Cyrus P. Zabetian, Matthew J. Farrer, Haplotype analysis of Lrrk2 R1441H carriers with parkinsonism, Parkinsonism & Related Disorders, 2009, 15, 6, 466

    CrossRef

  70. 70
    Seyedmehdi Shojaee, Zeinab Fazlali, Farzaneh Ghazavi, Setareh Sadat Banihosseini, Mohammad Hossein Kazemi, Khosro Parsa, Homa Sadeghi, Farzad Sina, Gholam-Ali Shahidi, Mostafa Ronaghi, Elahe Elahi, Identification of four novel potentially Parkinson's disease associated LRRK2 variations among Iranian patients, Neuroscience Letters, 2009, 467, 2, 53

    CrossRef

  71. You have free access to this content71
    Payal N. Gandhi, Shu G. Chen, Amy L. Wilson-Delfosse, Leucine-rich repeat kinase 2 (LRRK2): A key player in the pathogenesis of Parkinson's disease, Journal of Neuroscience Research, 2009, 87, 6
  72. 72
    Coro Paisán-Ruiz, LRRK2 gene variation and its contribution to Parkinson disease, Human Mutation, 2009, 30, 8
  73. 73
    Udhaya Kumari, E. K. Tan, LRRK2 in Parkinson’s disease: genetic and clinical studies from patients, FEBS Journal, 2009, 276, 22
  74. 74
    Cyrus P. Zabetian, Mitsutoshi Yamamoto, Alexis N. Lopez, Hiroshi Ujike, Ignacio F. Mata, Yuishin Izumi, Ryuji Kaji, Hirofumi Maruyama, Hiroyuki Morino, Masaya Oda, Carolyn M. Hutter, Karen L. Edwards, Gerard D. Schellenberg, Debby W. Tsuang, Dora Yearout, Eric B. Larson, Hideshi Kawakami, LRRK2 mutations and risk variants in Japanese patients with Parkinson's disease, Movement Disorders, 2009, 24, 7
  75. 75
    Lihua Yu, Fayun Hu, Xiaoyi Zou, Yi Jiang, Yan Liu, Xianghua He, Jing Xi, Ling Liu, Zhuolin Liu, Li He, Yanming Xu, LRRK2 R1628P contributes to Parkinson's disease susceptibility in Chinese Han populations from mainland China, Brain Research, 2009, 1296, 113

    CrossRef

  76. 76
    Zijuan Zhang, Jean-Marc Burgunder, Xingkai An, Yan Wu, Wenjun Chen, Jinhong Zhang, Yingcheng Wang, Yanming Xu, Yingru Gou, Guanggu Yuan, Xueye Mao, Rong Peng, LRRK2 R1628P variant is a risk factor of Parkinson's disease among Han-Chinese from mainland China, Movement Disorders, 2009, 24, 13
  77. 77
    Thomas Gasser, Mendelian forms of Parkinson's disease, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2009, 1792, 7, 587

    CrossRef

  78. 78
    Christian Wider, Zbigniew K Wszolek, Movement disorders: insights into mechanisms and hopes for treatment, The Lancet Neurology, 2009, 8, 1, 8

    CrossRef

  79. 79
    S. Lesage, A. Brice, Parkinson's disease: from monogenic forms to genetic susceptibility factors, Human Molecular Genetics, 2009, 18, R1, R48

    CrossRef

  80. 80
    Taku Hatano, Shin-ichiro Kubo, Shigeto Sato, Nobutaka Hattori, Pathogenesis of familial Parkinson’s disease: new insights based on monogenic forms of Parkinson’s disease, Journal of Neurochemistry, 2009, 111, 5
  81. 81
    Christian Wider, Sarah J. Lincoln, Michael G. Heckman, Nancy N. Diehl, Jeremy T. Stone, Kristoffer Haugarvoll, Jan O. Aasly, J. Mark Gibson, Timothy Lynch, Alex Rajput, Michele L. Rajput, Ryan J. Uitti, Zbigniew K. Wszolek, Matthew J. Farrer, Owen A. Ross, Phactr2 and Parkinson's disease, Neuroscience Letters, 2009, 453, 1, 9

    CrossRef

  82. 82
    John Hardy, Patrick Lewis, Tamas Revesz, Andrew Lees, Coro Paisan-Ruiz, The genetics of Parkinson's syndromes: a critical review, Current Opinion in Genetics & Development, 2009, 19, 3, 254

    CrossRef

  83. 83
    Saskia Biskup, Andrew B. West, Zeroing in on LRRK2-linked pathogenic mechanisms in Parkinson's disease, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2009, 1792, 7, 625

    CrossRef

  84. 84
    Dag Aarsland, Mona K Beyer, Martin W Kurz, Dementia in Parkinsonʼs disease, Current Opinion in Neurology, 2008, 21, 6, 676

    CrossRef

  85. 85
    Michael J. Devine, Patrick A. Lewis, Emerging pathways in genetic Parkinson’s disease: tangles, Lewy bodies and LRRK2, FEBS Journal, 2008, 275, 23
  86. 86
    Heather Melrose, Update on the functional biology ofLrrk2, Future Neurology, 2008, 3, 6, 669

    CrossRef